An interventional study of with and without wearing the power hip exoskeleton and adaptation training in Fatigue Condition and Adaptation, sponsored by National Cheng-Kung University Hospital. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by National Cheng-Kung University Hospital · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 87 studies in Fatigue with a site in Taiwan — 16 open to participants now, 19 under way, 3 of them phase 3. Fatigue · Taiwan.
Among the 87 studies in Fatigue with a site in Taiwan, this one is the 47th largest by planned enrollment of the 71 interventional ones that give a count, is one of 6 that started in 2026, is one of 59 with no phase, reaches primary completion later than 17 of the 18 other live ones, and was the 87th registered.
2,233 studies on the registry are indexed under Fatigue; 429 are open to participants now.
Browse Fatigue studies →16 of the 87 studies in Fatigue with a site in Taiwan are open now. Recruiting first, the newest first:
Novartis Pharmaceuticals · Sites in Taiwan, United States, Australia and 17 more countries
Ages 18+
Taipei City Hospital · Sites in Taiwan
Ages 18+
Alkermes, Inc. · Sites in Taiwan, United States, Australia and 12 more countries
Ages 18–70
Pfizer · Sites in Taiwan, United States, Australia and 18 more countries
Ages 18+
Chin-Wei Huang · Sites in Taiwan
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 240 Fatigue studies recruiting now, 112 (47%) set no upper age limit and 98 (41%) stop at 75 or younger; 23 take children under 18; 73 take healthy volunteers.
This study: 65 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
87 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 7 · Phase 3 6 · Phase 4 2
First in 2006; this study’s year is marked. 6 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 54 across 1,761 interventional studies indexed under Fatigue.
Median enrollment 60 across the 71 interventional studies, 120 across the 16 observational. Of the 56 that completed or were terminated, 3 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 87 have an industry lead sponsor. The 10 most frequent:
National Cheng-Kung University Hospital is the lead sponsor of 280 studies on the registry; 71 are open to participants now.
National Cheng-Kung University Hospital has 1 study filed under Fatigue — fewer than ten, so there is no comparison to draw.
7 of the studies in Fatigue with a site in Taiwan that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07455383Phase 3Alkermes, Inc.A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 | 2027-05 |
| NCT06854497Chiayi Christian HospitalThe Impact of Non-motor Symptom on the Outcome of Stroke Subjects | 2026-12-31 |
| NCT06851195Kaohsiung Medical University Chung-Ho Memorial HospitalEffect of Neuromuscular Electrical Stimulation of Lower Limbs on Improving Exercise Self-Efficacy, Dyspnea During Activity and Fatigue in Patients With Chronic Obstructive Pulmonary Disease | 2026-12-31 |
| NCT06736002Chin-Wei HuangEffects of Mega-dose Vitamin D Pulse and Maintenance Therapy on Seizure Frequency, Fatigue, and Quality of Life: A Prospective Study | 2026-12-31 |
| NCT05224518National Taiwan University Hospital Hsin-Chu BranchExercise Intervention to Improve Quality of Life in Patients With Colorectal Cancer | 2026-12-31 |
Add all 7 to your calendar (.ics) → With an account.
Among the 87 studies in Fatigue with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study includes three sections: The first section aims to investigate whether adaptation to using a powered hip exoskeleton can improve dual-task performance and alter prefrontal cortical modulation in older adults. The second and third sections aim to investigate whether a hip exoskeleton device can improve dual task performance and alter prefrontal cortical modulation for older adults during either muscle fatigue or mental fatigue conditions.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: with and without wearing the power hip exoskeleton · Behavioral: adaptation training
Under mental and muscle fatigue condition, to see how power hip exoskeleton device alter dual task walking performance and cortical load.
Instruct patients to walk with the power hip exoskeleton device for four adaptation sessions (6 minutes for each)
walking speed
meausred during the 40-meter oval walkway
Time frame: single experimental session (Day 1)
stride time
calculated over the 40-meter oval walkway
Time frame: single experimental session (Day 1)
Stride length
calculated during 40-meter walkway
Time frame: single experimental session (Day 1)
Functional Near Infrared spectroscopy (fNIRs)
reflect local cortical activation level alteration
Time frame: single experimental session (Day 1)
correct response rate
correct response rate of concurrent cognitive test
Time frame: single experimental session (Day 1)
reaction time
time require to response to the cognitive question
Time frame: single experimental session (Day 1)
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Started Oct 2026 (actual). Primary completion is estimated for Jul 2029, 33 months after the start.
Of 936 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 33 months is above that.
Counting every sponsor, half of 989 studies reached it within 12 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Cheng-Kung University Hospital →